• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染和全身炎症与 3/4 级肝性脑病相关,而不是氨,与肝硬化患者的死亡率无关。

Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.

机构信息

Institute of Liver Studies, King's College London School of Medicine, London, UK.

出版信息

J Hepatol. 2011 Apr;54(4):640-9. doi: 10.1016/j.jhep.2010.07.045. Epub 2010 Dec 1.

DOI:10.1016/j.jhep.2010.07.045
PMID:21163546
Abstract

BACKGROUND & AIMS: Patients with cirrhosis are prone to infection which is a frequent precipitant of hepatic encephalopathy (HE). Clinical studies have examined the importance of inflammation and infection in modulating the manifestation of symptoms of HE in acute liver failure and patients with cirrhosis and minimal/low grade HE. It would be logical to presume that this relationship persists in patients who develop severe HE in cirrhosis although this has not been examined to date.

METHODS

We report the findings of a prospective audit of 100 consecutive patients with cirrhosis admitted between Jan 2000 and March 2008 to a liver Intensive Care Unit (ICU) where HE was the primary indication for admission (59% Grade 3; 41% Grade 4). Haematological and microbiological data were collected at ICU admission, and organ scores and outcomes were recorded.

RESULTS

46% of patients had positive cultures taken within ± 48h from admission to ICU [25% blood] and a further 22% were culture negative but had evidence of systemic inflammation (SIRS). SIRS score (p=0.03) and SOFA score (p=0.006) were significantly higher in those patients with Grade 4 HE, who were also less likely to survive (p<0.001). HE grade/coma score did not correlate with ammonia, biochemistry or MELD score. Fifty-two percent of patients survived their ICU stay while the remainder developed progressive multiorgan failure and died; 38% survived to discharge, and 16% were transplanted.

CONCLUSIONS

These data support an association between infection/SIRS and not ammonia, in patients with cirrhosis that develop severe HE. The presence or absence of infection/SIRS did not determine survival.

摘要

背景与目的

肝硬化患者易发生感染,这是肝性脑病(HE)的常见诱因。临床研究已经研究了炎症和感染在调节急性肝功能衰竭和肝硬化患者及轻度/低度 HE 患者 HE 症状表现中的重要性。在发生肝硬化重度 HE 的患者中,这种关系持续存在是合乎逻辑的,尽管迄今为止尚未对此进行检查。

方法

我们报告了对 2000 年 1 月至 2008 年 3 月期间连续 100 例因 HE 而入住肝脏重症监护病房(ICU)的肝硬化患者的前瞻性审核结果(59%为 3 级;41%为 4 级)。在 ICU 入院时收集了血液学和微生物学数据,并记录了器官评分和结局。

结果

46%的患者在入住 ICU 的±48 小时内采集了阳性培养物[25%为血液],另有 22%的患者培养结果为阴性,但存在全身炎症反应综合征(SIRS)。4 级 HE 患者的 SIRS 评分(p=0.03)和 SOFA 评分(p=0.006)显著更高,且更不可能存活(p<0.001)。HE 分级/昏迷评分与氨、生化指标或 MELD 评分无关。52%的患者在 ICU 期间存活,其余患者则发生多器官功能衰竭并死亡;38%存活出院,16%接受了移植。

结论

这些数据支持在发生重度 HE 的肝硬化患者中,感染/SIRS 与氨无关,而不是与氨有关。感染/SIRS 的存在与否并不能决定生存。

相似文献

1
Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.感染和全身炎症与 3/4 级肝性脑病相关,而不是氨,与肝硬化患者的死亡率无关。
J Hepatol. 2011 Apr;54(4):640-9. doi: 10.1016/j.jhep.2010.07.045. Epub 2010 Dec 1.
2
Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study.用苯丁酸钠治疗入住重症监护病房的肝硬化患者肝性脑病:一项初步研究。
Fundam Clin Pharmacol. 2018 Apr;32(2):209-215. doi: 10.1111/fcp.12340. Epub 2018 Jan 11.
3
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).肝硬化患者因肝性脑病住院的特征、风险因素和死亡率,伴有和不伴有慢加急性肝衰竭(ACLF)。
J Hepatol. 2014 Feb;60(2):275-81. doi: 10.1016/j.jhep.2013.10.004. Epub 2013 Oct 12.
4
Ammonia levels and the severity of hepatic encephalopathy.氨水平与肝性脑病的严重程度。
J Coll Physicians Surg Pak. 2014 Mar;24(3):160-3.
5
Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures.肝性脑病与肝硬化患者的死亡率相关,与其他肝外器官衰竭无关。
Clin Gastroenterol Hepatol. 2017 Apr;15(4):565-574.e4. doi: 10.1016/j.cgh.2016.09.157. Epub 2016 Oct 5.
6
Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.轻微型肝性脑病和临界闪烁频率与肝硬化患者的生存相关。
Gastroenterology. 2015 Nov;149(6):1483-9. doi: 10.1053/j.gastro.2015.07.067. Epub 2015 Aug 21.
7
Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo.肝硬变患者肝性脑病的二级预防:L-鸟氨酸-L-天冬氨酸与安慰剂的双盲随机对照试验
Eur J Gastroenterol Hepatol. 2018 Aug;30(8):951-958. doi: 10.1097/MEG.0000000000001137.
8
[Prognostic indicators in patients with liver cirrhosis admitted to an intensive care unit].[入住重症监护病房的肝硬化患者的预后指标]
Gastroenterol Clin Biol. 1996;20(3):263-8.
9
CLIF-SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis.CLIF-SOFA评分和全身炎症反应综合征(SIRS)是酒精性肝硬化所致肝性脑病患者的独立预后因素。
Medicine (Baltimore). 2016 Jun;95(26):e3935. doi: 10.1097/MD.0000000000003935.
10
Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy.1级和轻微肝性脑病肝硬化患者的临床和病理生理特征
PLoS One. 2016 Jan 8;11(1):e0146076. doi: 10.1371/journal.pone.0146076. eCollection 2016.

引用本文的文献

1
Hyperammonaemia in Dogs Presenting with Acute Epileptic Seizures-More than Portosystemic Shunts.患有急性癫痫发作的犬的高氨血症——不止是门体分流。
Animals (Basel). 2025 Aug 30;15(17):2558. doi: 10.3390/ani15172558.
2
Ammonia-to-Urea Ratio: A Noninvasive First-Line Tool for Detecting Clinically Significant Portal Hypertension.氨与尿素比值:一种用于检测具有临床意义的门静脉高压的非侵入性一线工具。
JGH Open. 2025 Sep 8;9(9):e70273. doi: 10.1002/jgh3.70273. eCollection 2025 Sep.
3
Cetobacterium somerae-derived argininosuccinic acid promotes intestinal and liver ureagenesis to alleviate ammonia intoxication.
索氏栖热菌衍生的精氨琥珀酸促进肠道和肝脏尿素生成以减轻氨中毒。
Microbiome. 2025 Jul 12;13(1):163. doi: 10.1186/s40168-025-02152-4.
4
Blood-brain barrier dysfunction in hepatic encephalopathy: pathophysiology, diagnostic assessment and therapeutic perspectives.肝性脑病中的血脑屏障功能障碍:病理生理学、诊断评估及治疗前景
Metab Brain Dis. 2025 Jun 13;40(5):223. doi: 10.1007/s11011-025-01645-3.
5
Comparing efficacy of different scoring models to predict hepatic encephalopathy after TIPS in cirrhotic patients.比较不同评分模型预测肝硬化患者经颈静脉肝内门体分流术后肝性脑病的疗效。
Ann Med. 2025 Dec;57(1):2514082. doi: 10.1080/07853890.2025.2514082. Epub 2025 Jun 6.
6
Treatment with hydrogen-rich water protects against thioacetamide-induced hepatic encephalopathy in rats through stabilizing liver-brain disturbance.富氢水治疗通过稳定肝脑紊乱来预防硫代乙酰胺诱导的大鼠肝性脑病。
Sci Rep. 2025 May 23;15(1):17901. doi: 10.1038/s41598-025-02891-2.
7
Study on mechanism of iridoid glycosides derivatives from Fructus Gardeniae in treatment of hepatic encephalopathy by network pharmacology and molecular docking technology.基于网络药理学和分子对接技术对栀子中环烯醚萜苷类衍生物治疗肝性脑病作用机制的研究
Medicine (Baltimore). 2025 Jan 3;104(1):e41089. doi: 10.1097/MD.0000000000041089.
8
Hepatic Encephalopathy: Current Thoughts on Pathophysiology and Management.肝性脑病:关于病理生理学与管理的当前见解
Curr Neurol Neurosci Rep. 2025 Mar 28;25(1):28. doi: 10.1007/s11910-025-01415-9.
9
Role of Preoperative Neutrophil-Lymphocyte Ratio in Predicting Prognosis After Liver Transplantation for Chronic Liver Failure.术前中性粒细胞与淋巴细胞比值在预测慢性肝衰竭肝移植术后预后中的作用
Cureus. 2025 Mar 18;17(3):e80749. doi: 10.7759/cureus.80749. eCollection 2025 Mar.
10
Management of severe acute encephalopathy in the ICU: an expert consensus statement from the french society of intensive care medicine.重症监护病房中严重急性脑病的管理:法国重症医学学会专家共识声明
Ann Intensive Care. 2025 Mar 21;15(1):37. doi: 10.1186/s13613-025-01436-0.